기사 (249건) 리스트형 웹진형 타일형 Reba-eyeㆍReva-K get insurance benefit, Ameliebou down 24.5% Reba-eyeㆍReva-K get insurance benefit, Ameliebou down 24.5% Chronic Hepatitis B treatmentㆍSkyrizi get expanded insurance benefits, Reva-K receives new benefit [NEWSMP] Benefit standards for Rebamipide 0.1g/5ml, Sam... Pharmaceutical companies reach an average sales growth rate of 13.4% Pharmaceutical companies reach an average sales growth rate of 13.4% “Nabota has no impact on overseas export and sales” “Nabota has no impact on overseas export and sales” Semaglutide’s golden age, Ozempic annual sales reach KRW 1 trillion Semaglutide’s golden age, Ozempic annual sales reach KRW 1 trillion “Xpovio, the only hope for patients with multiple myeloma who have exhausted all treatments” “Xpovio, the only hope for patients with multiple myeloma who have exhausted all treatments” Market cap of KOSPI pharmaceutical index dropped by KRW 2.4481 trillion in January Market cap of KOSPI pharmaceutical index dropped by KRW 2.4481 trillion in January LucentisㆍVenclexta benefits cut by 30% and 12.2%, Vfend increases by 19.5% LucentisㆍVenclexta benefits cut by 30% and 12.2%, Vfend increases by 19.5% Atopic dermatitis treatment Dupixent gets insurance coverage recognition for children and adolescents [Newsmp] Dupixent, a biologic medication that was appro... BeiGene Korea general manager Yang Ji-hye BeiGene Korea general manager Yang Ji-hye SGLT2 inhibitors occupy a third of the K-Orange Book in 2022 SGLT2 inhibitors occupy a third of the K-Orange Book in 2022 One-fifth of KOSDAQ pharmaceuticals plunged more than 50% last year One-fifth of KOSDAQ pharmaceuticals plunged more than 50% last year 처음처음이전이전12345678910다음다음다음끝끝